Thrifting in the age of Ozempic
The popularity of Ozempic and other GLP-1 weight-loss drugs is prompting many affluent women to clear out their closets—a boon to savvy thrifters. For 10 years, I obsessed over finding a ’70s-era corduroy car coat like the one Wynona Ryder wears in the first season of Stranger Things. Not a “vintage inspired” fashion version, but […]
Pharmaceuticals, Vol. 19, Pages 9: Real-World Prescribing Patterns of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Older Adults with Type 2 Diabetes and Cardiometabolic Disease
Pharmaceuticals, Vol. 19, Pages 9: Real-World Prescribing Patterns of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Older Adults with Type 2 Diabetes and Cardiometabolic Disease Pharmaceuticals doi: 10.3390/ph19010009 Authors: Ibrahim S. Alhomoud Khalid A. Alamer Background/Objectives: Older adults with type 2 diabetes frequently have cardiovascular or kidney disease, and current guidelines strongly recommend the use […]
Sunlight.com Survey: 1 in 7 Americans Plan To Use GLP-1s in 2026
As GLP-1s grow in popularity, more Americans are rethinking weight loss in the new year KIRKLAND, Wash, Dec. 19, 2025 /PRNewswire/ — A new survey from Sunlight.com finds that interest in GLP-1 medications is rising as Americans set weight-loss goals for 2026. The December 2025 survey of…
Trump administration inks pricing deals with 9 drugmakers
The Trump administration finalized agreements Dec. 19 with nine pharmaceutical manufacturers to offer U.S. patients prescription drug prices aligned with the lowest rates paid by other developed nations. The companies — Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Genentech, Gilead Sciences, GSK, Merck, Novartis and Sanofi — agreed to provide “most-favored-nation” pricing on various therapies, including […]
I started a GLP-1 to save my own life. How friends reacted surprised me.
GLP-1 Drugs Linked With Chronic Cough
People with type 2 diabetes taking glucagon-like peptide-1 (GLP-1) receptor agonists were more likely to develop chronic cough than people using other second-line medications, a new study found.
What are GLP-1 medicines? Do they help with weight loss and diabetes, and what are their side effects?
GLP-1 medications are prescription treatments used in the UK to manage type 2 diabetes and, in certain cases, medically supervised weight loss. They function by mimicking hormones that control appetite and blood sugar, making people feel fuller. Only specific GLP-1 drugs are licensed by the MHRA, and they must be prescribed by healthcare experts. Regulators […]
The Century of History Shaping the Debate Over GLP-1s
The debate over whether insurers should pay for GLP-1 drugs like Ozempic and Wegovy has revived a familiar American argument about why people get sick. Some commentators have insisted that the powerful weight-loss drugs are “shortcuts” for people unwilling to exercise greater self-control, a concern echoed in coverage noting that experts worry too many patients […]
Novo Nordisk Files NDA for Next-Generation Obesity Drug CagriSema
Novo Nordisk NVO announced the submission of a new drug application (NDA) to the FDA, seeking approval for its next-generation once-weekly injection, CagriSema, to reduce excess body weight and maintain weight reduction in the long term in adults with obesity or overweight. The FDA is expected to review the application in 2026. The candidate is intended […]
Altimmune advances in MASH; New China obesity biotech; Ipsen Phase 2 fail
Plus, news on: EpimAb, Boehringer and Nxera, Syneron, Amphix Altimmune goes to Phase 3 in MASH: The drug developer’s Phase 2 trial of pemvidutide, a GLP-1/glucagon agonist, failed in June. But based on a longer …